We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What Is a Grawitz Tumor?

By C. Webb
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

A Grawitz tumor is a tumor found in renal cell carcinoma (RCC), a kidney cancer that begins in the tubes that separate waste products from blood. When a Grawitz tumor and RCC are confined to the renal tubes, treatment often includes removal of the kidney and affected tubes. Black patients have a slightly increased risk of developing RCC.

This disease is typically symptomless until in the advanced stages. Blood is found in urine in 60 percent of the cases. Urine containing blood can be rust or brown in color, or have a pink tinge to it. Twenty-five percent of Grawitz tumor cancers include an abdominal mass. Weight loss occurs in approximately 30 percent of patients.

In addition to the more common symptoms, polycythema occurs in five percent of patients. This is a specific type of anemia directly related to the disease. Two percent of male patients report a swelling of the left testicle. Metastasized Grawitz tumor/RCC can infiltrate bones and cause fractures to occur. A cancer has metastasized when it leaves the point of origin and spreads to other parts of the body.

Sensitivity to cold, frequent unexplained fevers, and chronic fatigue also plague patients with Grawitz tumors. This disease impacts more females than males. Its incidence has seen a steady increase in recent years.

Risk factors for a Grawitz tumor and RCC include obesity and smoking. In addition, those on dialysis for cystic disease are 30 times more likely to develop RCC than others. Ultrasound imaging is the most accurate diagnostic tool for RCC. If a tumor is seen, the next step is a CAT (CT) scan of the abdomen to verify and stage the disease. Staging gives a numeric value to how advanced the cancer is.

Forty percent of RCC is diagnosed while still confined to the kidneys. Such cases have a 90-percent cure rate following surgical kidney removal. Once the disease has metastasized, the survival rate is less promising. Chemotherapy, immunotherapy, and radiation are typically introduced. A medical evaluation should be sought any time symptoms of RCC are present.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.